StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Saturday. The firm issued a hold rating on the stock.

ObsEva Stock Performance

NASDAQ:OBSV opened at $0.01 on Friday. The firm has a market cap of $389,855.00, a PE ratio of -0.01 and a beta of 0.68. The stock has a fifty day moving average price of $0.02 and a 200 day moving average price of $0.04. ObsEva has a 12-month low of $0.08 and a 12-month high of $2.14.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.